BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 37288246)

  • 21. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
    Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
    Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging plus X: multimodal models of neurodegenerative disease.
    Oxtoby NP; Alexander DC;
    Curr Opin Neurol; 2017 Aug; 30(4):371-379. PubMed ID: 28520598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Plasticity of the Hippocampus in Neurodegenerative Diseases.
    Weerasinghe-Mudiyanselage PDE; Ang MJ; Kang S; Kim JS; Moon C
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroimaging diagnosis in neurodegenerative diseases.
    Szymański P; Markowicz M; Janik A; Ciesielski M; Mikiciuk-Olasik E
    Nucl Med Rev Cent East Eur; 2010; 13(1):23-31. PubMed ID: 21154313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Nrf2 in aging, Alzheimer's and other neurodegenerative diseases.
    George M; Tharakan M; Culberson J; Reddy AP; Reddy PH
    Ageing Res Rev; 2022 Dec; 82():101756. PubMed ID: 36243357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel population of progenitor cells expressing cannabinoid receptors in the subependymal layer of the adult normal and Huntington's disease human brain.
    Curtis MA; Faull RL; Glass M
    J Chem Neuroanat; 2006 Apr; 31(3):210-5. PubMed ID: 16533591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of magnetic resonance imaging in the diagnosis of Parkinson's disease: a review.
    Al-Radaideh AM; Rababah EM
    Clin Imaging; 2016; 40(5):987-96. PubMed ID: 27288741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology.
    Santiago JA; Bottero V; Potashkin JA
    Front Aging Neurosci; 2017; 9():166. PubMed ID: 28611656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic Spine Pathology in Neurodegenerative Diseases.
    Herms J; Dorostkar MM
    Annu Rev Pathol; 2016 May; 11():221-50. PubMed ID: 26907528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Functional Roles of Curcumin on Astrocytes in Neurodegenerative Diseases.
    Mohammadi A; Hosseinzadeh Colagar A; Khorshidian A; Amini SM
    Neuroimmunomodulation; 2022; 29(1):4-14. PubMed ID: 34496365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neural stem cells could serve as a therapeutic material for age-related neurodegenerative diseases.
    Suksuphew S; Noisa P
    World J Stem Cells; 2015 Mar; 7(2):502-11. PubMed ID: 25815135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prion model for progression and diversity of neurodegenerative diseases.
    Stopschinski BE; Diamond MI
    Lancet Neurol; 2017 Apr; 16(4):323-332. PubMed ID: 28238712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mast Cells in Neurodegenerative Disease.
    Jones MK; Nair A; Gupta M
    Front Cell Neurosci; 2019; 13():171. PubMed ID: 31133804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eye movements in neurodegenerative diseases.
    MacAskill MR; Anderson TJ
    Curr Opin Neurol; 2016 Feb; 29(1):61-8. PubMed ID: 26641817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network.
    Sertbaş M; Ulgen K; Cakır T
    FEBS Open Bio; 2014; 4():542-53. PubMed ID: 25061554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Monoamine oxidase activity in brain regions and organs of patients with Parkinson's disease and Huntington's disease and serum MAO activity of patients with Huntington's disease as compared with neurologically healthy individuals (author's transl)].
    Schneider G; Oepen H; von Wedel HR
    Arch Psychiatr Nervenkr (1970); 1981; 230(1):5-15. PubMed ID: 6455104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of Long Non-coding RNAs in the Development of Aging-Related Neurodegenerative Diseases.
    Ni YQ; Xu H; Liu YS
    Front Mol Neurosci; 2022; 15():844193. PubMed ID: 35359573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.